Multimodal AI fuses proteomic and EHR data for rational prioritization of protein biomarkers in diabetic retinopathy.

Purpose: There is a need for novel therapies for diabetic retinopathy (DR) because existing therapies treat only certain features of DR and do not work optimally for all patients. While proteomic studies provide insight into disease pathobiology, they are often limited to small sample sizes due to high costs, limiting their generalizability and reproducibility. Moreover, they often yield lists of tens to hundreds of proteins with differential expression, making it difficult to prioritize the most biologically relevant biomarkers beyond using arbitrary fold-change and false-detection rate cutoffs. Here, we applied a two-stage multimodal AI approach: first, we integrated EHR and proteomics data to rationally prioritize candidate protein biomarkers and, next, validated these biomarkers in an independent cohort. These protein biomarkers of DR are rooted in the EHR data and thereby more likely to be biological drivers of disease. Methods: We obtained EHR data from a large number of patients with and without DR (N=319,997) from the STARR-OMOP database and obtained aqueous humor liquid biopsies from a subset of these patients (N=101) for high-resolution proteomic profiling. We developed Results: t-distributed stochastic neighbor embedding (t-SNE) analysis of EHR and proteomics data identified proteins clustering with related EHR features. Levels of STX3 and NOTCH2, proteins involved in retinal function, were correlated with a diagnosis of macular edema, a record of a visual field exam, and a prescription for latanoprost, highlighting protein-EHR alignment. The pretrained, multimodal COMET model was superior (AUROC=0.98, AUPRC=0.91) compared to models generated using either EHR or proteomics data alone or without pretraining (AUROC: 0.76 to 0.92; AUPRC: 0.47 to 0.74). The proteins SERPINE1, QPCT, AKR1C2, IL2RB, and SRSF6 were prioritized by the COMET model compared to the models without pretraining, supporting their potential role in DR pathobiology, and were subsequently validated in an independent cohort. Conclusion: We used multimodal AI to prioritize protein biomarkers of DR that are most strongly linked to EHR elements, as well as identifying other protein biomarkers associated with disease features like diabetic macular edema. These findings serve as a foundation for future mechanistic studies and highlight the synergistic value of using multimodal AI to fuse EHR and proteomics data for enhanced proteomics analysis.